Skip to content
Bored Studies
RecruitingAccepts healthy volunteers

Goal Setting to Promote Physical Activity Adherence in Midlife Adults

Arizona State University · with National Institute on Aging (NIA) · NCT05980052

View Study & Apply (opens in a new tab)

Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.

Key facts

Compensation
Not posted. Ask the study team before screening.
Who can join
Ages 45–65 · All sexes
Healthy volunteers
Accepted
Study type
Interventional · Not applicable
Target enrollment
144
US sites recruiting
1
Study start
July 17, 2023
Record last updated
July 17, 2026

Status re-checked against ClinicalTrials.gov within the last 12 hours.

What the study is about

Engaging in regular physical activity during midlife is a key lifestyle behavior associated with reduced risk for Alzheimer's disease and related dementias (AD/ADRD). Yet nearly half of midlife adults (48%) do not meet national physical activity guidelines. The purpose of this mechanistic trial is to identify effective goal setting techniques to enhance psychosocial processes of self-regulation for the successful promotion of PA and adherence to national PA guidelines among midlife adults, with the long-term goal of reducing AD/ADRD risk

Being studied: Physical Activity

Conditions: Physical Activity; Exercise

Eligibility criteria

Copied from the official record. The study team makes the final decision at screening.

Show full criteria

Inclusion Criteria

  • Aged 45 to 65 years
  • BMI between 30 kg/m2 to 50 kg/m2
  • Participants must weigh a minimum of 110 pounds
  • Engaging in 60 minutes or less of self-reported moderate-to-vigorous physical activity at screening (based on Exercise Vital Sign Questionnaire)
  • Self-reported ownership of a smartphone with an iOS or Android operating system (necessary for participants to track their activity using a Fitbit activity monitor)

Exclusion Criteria

  • Endorsing an item on the Physical Activity Readiness Questionnaire (PAR-Q), unless a physician's note is provided
  • Resting blood pressure greater than 200/110 mmHG as assessed at the baseline study assessment (unless a physician's note is provided)
  • Pregnant or planning to become pregnant in next 8-months (Phase 1) or 12 months (Phase 2)
  • Plans to relocate out of metropolitan Phoenix, Arizona area in the next 8-months (Phase 1) or 12 months (Phase 2)
  • Participation in another physical activity, nutrition or weight loss program at time of screening or at any time during the intervention
  • Individuals with mild cognitive impairment (MCI), as determined by either a self-report of receiving a diagnosis of MCI from a health care provider or as assessed by the Montreal Cognitive Assessment (MoCA) at the study orientation session. A score \< 26 is an exclusion criterion for US born participants. A score of \<23 is an exclusion for participants born outside of the US who completed their high school education in a country where English is not the primary language.
  • Being previously prescribed one of the 5 approved Alzheimer's medications, including: Donepezil (Aricept), Rivastigmine (Exelon), Galantamine (Razadyne), Memantine (Namenda), Memantine + Donepezil (Namzaric)
  • Score of 16 or higher on the Center for Epidemiological Studies-Depression Scale (CES-D)
  • Self-reported current diagnosis of major depression
  • Currently taking 2 or more ant-depression drugs
  • History of stroke
  • Incarcerated individuals (i.e., Prisoners)

Recruiting US locations

  • Arizona State University

    Phoenix, AZ 85004

    Site contact: Rodney P Joseph · 602-496-0772 · rodney.joseph@asu.edu

Study contacts (from the official record)

  • Rodney Joseph, PhD · 602-496-0772 · rodney.joseph@asu.edu
  • Molly Maxfield, PhD · 602-496-2311 · molly.maxfield@asu.edu
All neurology studies in Arizona →
Goal Setting to Promote Physical Activity Adherence in Midlife Adults (NCT05980052) | Bored Studies